β blockers (β-adrenoceptor blockers) are known to be used for the prophylactic treatment of migraine. The improvement of migraine in the patients who recieved propranolol for angina pectoris revealed the effectiveness of propranolol in migraine prophylaxis. Many clinical trials have confirmed that propranolol is effective in the prophylactic treatment of migraine. Other β-blocking drugs, namely nadolol, metoprolol, atenolol, timolol and bisoprolol, have also been demonstrated to be effective in the prophylaxis of migraine. In contrast, several β blockers with intrinsic sympathetic activity (ISA), such as alprenolol, oxprenolol, pindolol and acebutolol, have not been demonstrated to be effective in migraine prophylaxis. In this review, we have descrived the pharmacologic background and pharmacokinetics of the β blockers that demonstrated a prophylactic effect for migraine will be described. We have also reviewed the results of clinical trials of β-blocking drugs for migraine.
|ジャーナル||Brain and Nerve|
|出版物ステータス||Published - 2009 10 1|
ASJC Scopus subject areas
- Clinical Neurology